Coloplast reaffirms FY2026 sales guidance at $4.499B
Coloplast (OTC: CLPBY) affirms FY2026 sales guidance of $4.499 billion versus a $4.420 billion estimate.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.